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ABSTRACT
ELAV is a neuron-specific RNA-binding protein in
Drosophila that is required for development and
maintenance of neurons. ELAV regulates alternative
splicing of Neuroglian and erect wing (ewg) tran-
scripts, and has been shown to form a multimeric
complex on the last ewg intron. The protein has
three RNA recognition motifs (RRM1, 2 and 3) with a
hinge region between RRM2 and 3. In this study, we
used the yeast two-hybrid system to determine the
multimerization domain of ELAV. Using deletion
constructs, we mapped an interaction activity to a
region containing most of RRM3. We found three
conserved short sequences in RRM3 that were
essential for the interaction, and also sufficient to
give the interaction activity to RRM2 when intro-
duced into it. In our in vivo functional assay, a
mutation in one of the three sequences showed
reduced activity in splicing regulation, underlining
the functional importance of multimerization.
However, RRM2 with the three RRM3 interaction
sequences did not function as RRM3 in vivo, which
suggested that multimerization is not the only
function of RRM3. Our results are consistent with
a model in which RRM3 serves as a bi-functional
domain that interacts with both RNA and protein.
INTRODUCTION
The RNA recognition motif (RRM) is the most common
RNA-binding domain, and also one of the most abundant
protein domains in eukaryotes (1–3). The RRM consists of
about 80–90 amino acids, and has the conserved structure
oftwoa-helicespackedagainstfouranti-parallelb-strands.
Structural studies have shown that it interacts with RNA
through amino acids located on the b-strands (4–9). In
addition to RNA-binding, it has been shown that RRMs
can also serve as the site of protein–protein interactions.
Such a case was initially reported for the interactions
between U2 small nuclear ribonucleoprotein particle
(snRNP) B00 and A0 proteins (10–13), and later structural
studies, including that of other proteins, revealed that the
protein–protein interactions often, but not always, occur
through amino acids on the a-helices of the RRM (8,14–
21). This dual interacting capability of the RRM domain
might explain its prevalence.
The ELAV protein family is a conserved RNA-binding
protein family found in animals from Caenorhabditis to
humans. Its characteristic structure is the three RRMs
(RRM1, 2 and 3) with a ‘hinge’ region of about 60–80
amino acids separating the second and third RRMs.
Mammals have four members of the family called Hu
proteins (HuR, HuB, HuC and HuD) that have been
implicated in stabilization and/or translation activation of
mRNAs containing AU-rich elements (AREs) (22–24).
Drosophila has three ELAV-family proteins (ELAV, Rbp9
and Fne). ELAV is speciﬁcally expressed in all neurons in
Drosophila, and elav null mutants show embryonic lethal
phenotype with developmental defects in the nervous
system (25,26). It has been shown that ELAV regulates
alternative splicing of Neuroglian (Nrg) and erect wing
(ewg) transcripts, by binding to their introns to produce
neuron speciﬁc isoforms (27–30). Additionally, ELAV has
been shown to autoregulate its own message (31–33).
Recently, ELAV has been shown to form a multimeric
complex on the ewg intron RNA. It appears that ELAV in
solution is mainly in a tetramer-conﬁguration without the
substrate RNA, and is assembled into a larger dodeca-
meric complex upon binding to the target RNA (34).
Mammalian ELAV family proteins have also been
shown to form multimers (35–37). Therefore, it is likely
that multimerization is a common feature shared by
the ELAV-family proteins, and an important part of the
mechanism by which they exert their eﬀect on the
bound RNA.
In this study, we show that one of the major sites for
ELAV–ELAV interaction activity is located in RRM3 and
a small adjacent region of the hinge. Three short sequences
in RRM3 are shown to be necessary for the interaction,
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RRM2 when introduced into it. However, RRM3 requires
more than the three short sequences to function in vivo,
suggesting that acting as a multimerization domain is not
the sole function of RRM3. Our data are consistent with a
model in which RRM3 acts as a bi-functional domain that
interacts with both RNA and protein.
MATERIALS AND METHODS
Plasmid construction
To construct plasmids for the yeast two-hybrid assay,
we used pGBKT7 and pGADT7 vectors (Clontech) for
the GAL4 DNA-binding-, and transcription-activation-
domain fusions, respectively. Both fusions were
N-terminal fusions; i.e. the DNA-binding, or activation
domain was fused to the N-terminus of the protein to be
tested. The full-length and truncated elav coding sequences
were ampliﬁed by PCR from an elav cDNA clone, digested
with EcoRI and BglII, and subcloned between EcoRI and
BamHI sites of pGBKT7 and pGADT7 vectors.
For construction of hinge-RRM1 (eH1) and hinge-
RRM2 (eH2) cDNAs, the elav RRM1 and 2 coding
sequences were PCR-ampliﬁed with primers that have the
30 end sequence of the hinge region fused to the 50 region
of the RRM1 or 2 coding sequence. The fused hinge
sequence would anneal to the corresponding site of the
hinge region during the next round of PCR. The
secondary PCRs were performed in which eH1 or eH2
were ampliﬁed from mixed templates of the ﬁrst PCR
product and pGADT7-eH. The resulting PCR fragments
were digested with EcoRI and BglII, and subcloned into
EcoRI/BamHI sites of pGADT7.
The mutant hinge-RRM3 constructs (eH3mu1-7) were
generated by site-directed PCR mutagenesis. For each
mutation, a complimentary pair of primers was designed
at the target site to replace a certain RRM3 sequence
with the corresponding sequence from RRM2. In the
primary PCRs, the 50 and 30 parts were ampliﬁed
separately using one of the complimentary mutagenic
primers at one end. The PCRs produced the 50 and 30 parts
of the constructs overlapping with each other for the
length of the mutagenic primers. The 50 and 30 parts were
joined together by the secondary PCRs in which a mixture
of the two primary PCR products was used as a template.
The secondary PCR fragments were digested with EcoRI
and BglII, and subcloned into EcoRI/BamHI sites of
pGADT7.
The eH3mu8 was constructed in a similar way as the
other mutant hinge-RRM3 constructs were made, but
with three separate primary PCRs; from the 50 end of the
hinge to the ﬁrst two mutations (ETEE and W), from the
ﬁrst two mutations to the third mutation site (MTNY),
and from the third mutation to the 30 end of RRM2. The
three primary PCR fragments were joined together by
the secondary PCR with the primers at both ends of the
eH3mu8. The secondary PCR fragment was digested with
EcoRI and BglII, and subcloned into EcoRI/BamHI sites
of pGADT7.
For Rbp9 and fne constructs, the coding sequences
of Rbp9 and fne were ampliﬁed by PCR from cDNA
prepared from adult Drosophila RNA. The ampliﬁed Rbp9
coding sequence was digested with BglII and XhoI, and
subcloned into BamHI/SalI and BamHI/XhoI sites of
pGBKT7 and pGADT7, respectively. The fne coding
sequence was digested with EcoRI and BglII, and
subcloned into EcoRI/BamHI sites of pGBKT7 and
pGADT7.
For the upstream activating sequence (UAS) constructs,
PCRs were performed to put a mutant RRM in place of
RRM3 in the full length elav cDNA. The pGADT7 with a
mutant hinge-RRM insert (eH3mu4, eH3mu8,o reH2)
was digested with HpaI, and used as a template together
with pGBKT7-eQ12H. With the primers at the 50 end of
elav coding sequence and downstream to the cloning site
of pGADT7, the full length elav coding sequences with a
mutant RRM3 were ampliﬁed. The PCR fragments were
digested with EcoRI and XhoI, and subcloned ﬁrst into
EcoRI/XhoI sites of pGADT7, then cut out by BglII and
XhoI digestion, and subcloned into BglII/XhoI sites of the
pUAST vector (38). Likewise, the control elav coding
sequence was excised from the pGADT7-eQ12H3 con-
struct with BglII and XhoI digestion, and subcloned into
BglII/XhoI sites of pUAST. All the UAS-elav constructs
have hemagglutinin (HA) epitope tag sequence at the
N-terminus that is derived from pGADT7.
All the subcloned PCR fragments were fully sequenced
to conﬁrm the absence of inadvertent mutations intro-
duced during PCR. See Supplementary Data for all the
primer sets used for the PCRs (Table S1) and their
sequences (Table S2).
Yeasttwo-hybrid assay
The Matchmaker Two-Hybrid System 3 (Clontech) was
used for the two-hybrid interaction assays. The
Saccharomyces cerevisiae Y187 and AH109 strains
(Clontech) were transformed with the pGBKT7 and
pGADT7 constructs, respectively. To test two-hybrid
interactions, Y187 with a pGBKT7 construct and AH109
with a pGADT7 construct were mated, and the resulting
diploids were tested for two-hybrid reporter gene activa-
tion. Each mating culture was plated on a SD/-Ade/-His/-
Leu/-Trp testing plate to examine the activation of both
ADE2 and HIS3 reporter genes, as well as on a SD/-Leu/-
Trp plate to conﬁrm mating success. Colony formation on
the SD/-Ade/-His/-Leu/-Trp plate was scored after 6 days
of incubation at 308C. In all ﬁgures, ‘+’ means yeast
colony formation indicating interaction between the two
proteins, and ‘ ’ means no or very few colony formations
indicating no or very weak interaction (see Figure 3B for
examples of ‘+’ and ‘ ’ results). All the constructs were
tested to conﬁrm that they did not activate the reporter
gene expressions by themselves.
Immunoprecipitation
For co-immunoprecipitation (co-IP), adult ﬂies of the
following genotypes were prepared: elav
e5; elav
DvORF/
CyO, elav
e5; elav
DvORF/+; elav
 13/+, elav
e5; elav
 13/
TM3 Ser, UAS-eQ12H3/+; Hsp70-GAL4/+ and
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e5 (26) is a null allele of elav,
elav
DvORF (39) and elav
 13 (40) are elav transgenes, UAS-
eQ12H3 is HA-tagged elav under the control of UAS, and
Hsp70-GAL4 (P{GAL4-Hsp70.PB}; Bloomington
Drosophila Stock Center) is GAL4 driven by the Heat
shock protein 70 (Hsp70) promoter. A 378C heat-shock
was applied for 30min to UAS-eQ12H3/+; Hsp70-GAL4/
+ and Hsp70-GAL4/+ ﬂies 3h and 30min before head-
collection. Eighty heads were collected for each genotype
and homogenized in 250ml of immunoprecipitation buﬀer
[IPB; 50mM Tris–HCl pH 7.5, 50mM NaCl, 0.1% Triton
X-100, Complete Mini Protease Inhibitor Cocktail Tablet
(Roche)]. The homogenate was centrifuged, the super-
natant was divided into two equal volumes of 110ml, and
the RNase Cocktail (Ambion; 0.1 U RNase A and 4U
RNase T1) was added to one (RNase +). Both RNase +
and   homogenates were incubated at room temperature
(RT) for 30min. After the incubation, the homogenate
was centrifuged again and 100ml of the supernatant
was recovered. The Immobilized Protein A (Pierce
Biotechnology) was pre-washed with IPB, then incubated
with either the mouse anti-ELAV monoclonal antibody
(mAb) 7D (for ELAV
DvORF) or the mouse anti-HA mAb
F-7 (Santa Cruz Biotechnology; for HA-tagged ELAV) in
IPB at 48C for several hours. About 10ml of the beads were
added to the homogenate after being washed with IPB. The
mixturewas incubatedat48Cfor1hand30minwithgentle
rotation. The beads were washed with IPB. Then 10mlo f
2 SDS sample buﬀer [100mM Tris–HCl pH 6.8, 4%
sodium dodecyl sulfate (SDS), 2% 2-mercaptoethanol,
20% glycerol, 0.001% bromophenol blue] was added to the
beads, and incubated at 958C for 8min. The precipitated
proteins were separated by SDS polyacrylamide gel
electrophoresis and western blotting was probed by the
rat anti-ELAV anti-serum.
Germline transformation
Df(1)w; Ki p
p D2-3/+ embryos were injected with the
pUAST constructs (41,42). The germline transformants
were recovered based on [w
+] eye color, and transgenic
lines were established by standard procedures.
Immunostaining
The yw ; UnGA; dpp-GAL4 (P{GAL4-dpp.blk1})
(43)/TM6B Tb females were crossed with males of one
of the UAS-elav lines. The [Tb
+] wandering third instar
larvae in the next generation were used for dissection.
Wing discs were dissected in phosphate-buﬀered saline
(PBS) and ﬁxed in 4% paraformaldehyde in PBS for
30min at RT. The wing discs were washed in 0.3% Triton
X-100 in PBS (PBT), blocked in 5% normal goat serum in
PBT for 2h and 30min at RT, and incubated with
primary antibodies of the mouse anti-ELAV mAb 7D and
the rabbit anti-GFP polyclonal antibody (Torrey Pines
Biolabs) at the dilutions of 1:100 and 1:200, respectively,
in PBT for overnight at 48C. The secondary antibody
incubation was carried out with the Cy5-conjugated
donkey anti-mouse immunoglobulin antibody (Jackson
ImmunoResearch Laboratories) and the ﬂuorescein-
conjugated goat anti-rabbit immunoglobulin antibody
(Jackson ImmunoResearch Laboratories) at the dilution
of 1:200 each in PBT for 2h and 30min at RT. The wing
discs were mounted with 70% glycerol in PBS after
washing with PBT.
Confocal microscopy and image analysis
Immunoﬂuorescent images were acquired by Leica TCS
SP2 mounted on Leica DM IRE2 inverted microscope.
Intensities of ﬂuorescence were measured by ImageJ
software (National Institutes of Health) from average
Z-series projection images of the wing discs. The ELAV
(Cy5) and GFP (ﬂuorescein) signals in the dpp expression
pattern as well as in the background were measured for
eight wing discs for each genotype. The background signal
was subtracted from the signal in the dpp-pattern to obtain
the compensated signal intensity for each disc. The
compensated GFP signal was normalized by the compen-
sated ELAV signal for each disc, and the average and
conﬁdence interval of the normalized GFP signal was
calculated for eight wing discs of each genotype.
RESULTS
All Drosophila ELAV-family proteins interact
with eachother
It has been shown that ELAV forms multimeric complexes
in the presence or absence of substrate RNA (34),
and mammalian Hu proteins form homo- and hetero-
multimers (35–37). In our yeast two-hybrid screening
of a Drosophila embryonic cDNA library for ELAV-
interacting proteins, we identiﬁed ELAV itself and Fne,
another ELAV-family protein in Drosophila, as the
strongest ELAV-interacting proteins (Toba and White,
our unpublished data). This suggests that Drosophila
ELAV-family proteins also interact with each other as Hu
proteins do. To examine interactions among all three
Drosophila ELAV-family proteins, we cloned the cDNA
of elav, Rbp9 and fne into yeast two-hybrid vectors. The
interactions between the proteins in yeast were assessed by
looking at colony formation on the testing plate that
requires activation of both of the two reporter genes
(see Materials and Methods section for details).
Interactions were positive in all the combinations
(Figure 1A), which suggests that Drosophila ELAV-
family proteins may form homo- and hetero-multimers
under these conditions.
ELAV–ELAV interaction requires RNA
To examine ELAV multimerization in the in vivo environ-
ment, we conducted co-IP from Drosophila extracts in
two diﬀerent ways: (i) A protein extract was prepared
from ﬂies expressing both the elav
DvORF (39) and elav
 13
(40) transgenes over the elav
e5 (null) background. The
elav
DvORF expresses ELAV of D. viliris that has a larger
molecular weight than D. melanogaster ELAV. The
ELAV
 13 protein has a 13 amino acid deletion in
the ﬁrst RRM that includes the epitope recognized by
the monoclonal anti-ELAV antibody. The ELAV
DvORF
was IP-ed with the monoclonal antibody to see if the
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 13 would be co-IP-ed; (ii) The HA-tagged ELAV
was expressed in adult Drosophila using the GAL4-UAS
system (38), and the HA-ELAV was IP-ed with an anti-
HA antibody to examine if the endogenous ELAV would
be co-IP-ed with it. In both cases, ELAV protein that was
not recognized by the antibody was co-IP-ed with the
other form of the protein (Figure 1B lane 6 and Figure 1C
lane 3). However, the interactions seemed RNase sensitive
since RNase treatment of the protein extract made co-IP-
ed proteins undetectable in both cases (Figure 1B lane 7
and Figure 1C lane 4). This result suggests that either the
interaction is mediated by RNA, or binding of the RNA
allows a conformational change in ELAV that facilitates
the protein–protein interaction.
Mapping ofELAV multimerization domains
ELAV consists of three RRMs, an N-terminal alanine/
glutamine (AQ)-rich region, and a hinge region between
the RRM2 and 3 (Figure 2A). To map the region that is
responsible for the ELAV–ELAV interaction, we made a
series of deletion constructs and tested interactions using
the yeast two-hybrid system. Interaction activity required
the presence of both the hinge region and RRM3 in all
cases but of eQ12 and eQ12H constructs in Figure 2B. The
eH3 fragment interacted with itself (Figure 2B). In
addition to the hinge-RRM3 region, the N-terminal
AQ-rich region seemed to contribute to the interaction
since the constructs that lack RRM3 or both hinge and
RRM3 (eQ12 and eQ12H in Figure 2B) still retained some
interaction activity as long as they had the AQ-rich region
(compare eQ12 with e12, eQ12H with e12H in Figure 2B).
Our results suggest the involvement of both the AQ-rich
and hinge-RRM3 regions in the interaction. We resolved
to pursue the activity of the hinge-RRM3 region since it is
likely to be a general property of ELAV-family proteins,
as the AQ-rich region is not present in any other ELAV-
family protein. Additionally, the AQ-rich region is not
essential to the vital function of ELAV (44).
We narrowed down the activity within the hinge-RRM3
region with deletion constructs of the hinge-RRM3
fragment. The result suggests that N-terminal two thirds
of the hinge region and the C-terminal 18 amino acids of
RRM3 are dispensable for the interaction (Figure 2C).
The break point of the eSH3 in Figure 2C is the
C-terminal end of the sequence required for nuclear
localization of the protein (45). The construct eSHbabba
in Figure 2C that consists of most of the RRM3 and a
C-terminal part of the hinge was the smallest fragment
that showed the same interaction activity as the original
eH3 fragment.
Threeconserved short sequences inRRM3 playacritical
role inELAV–ELAV interaction
To identify amino acids responsible for the interaction in
the hinge-RRM3 region, we looked for evolutionary
conservation within the region where we mapped the
interaction activity. While we found conserved sequences
in the RRM3, the sequence in the hinge region was very
divergent and we hardly found any conservation within
the region where interaction activity was mapped (data
not shown). Although it is still possible that the region has
important structures for the interaction without apparent
sequence conservation, we focused our investigation on
the RRM3.
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Figure 1. (A) Yeast two-hybrid interactions between Drosophila ELAV-
family proteins. In the matrix, ‘+’ and ‘ ’ indicate positive and
negative interactions in the yeast two-hybrid assay, respectively. The
results show that all Drosophila ELAV-family proteins, ELAV, Rbp9
and Fne, interact with themselves as well as each other. ‘Vector only’
means empty pGBKT7 and pGADT7 vectors for the DNA biding and
activation domain fusions, respectively. ND, not determined. (B and C)
ELAV–ELAV interaction is sensitive to RNase treatment. (B) Both
ELAV
DvORF and ELAV
 13 were expressed in the elav null mutant ﬂies.
Immunoprecipitation (IP) was performed with the anti-ELAV mAb 7D
which does not recognize ELAV
 13, and western blot was probed with
the anti-ELAV polyclonal antiserum. ELAV
 13 was co-IPed with
ELAV
DvORF (lane 6), and the co-IPed ELAV
 13 became undetectable
with RNase treatment (lane 7). The elav
e5; elav
DvORF/CyO (lanes 1, 4
and 5) and elav
e5; elav
 13/TM3 Ser (lanes 3, 8 and 9) are negative
controls in which ELAV
DvORF and ELAV
 13 were solely expressed,
respectively. (C) HA-tagged ELAV was expressed in the ﬂies with
Hsp70-GAL4 driver, and an anti-HA mAb was used for IP. Western
blot was probed with the anti-ELAV polyclonal antiserum. The
endogenous ELAV was co-IPed with HA-ELAV (lane 3), and the
interaction was disrupted by RNase treatment (lane 4). The Hsp70-
GAL4 (lanes 2, 5 and 6) is a negative control that does not have the
HA-tagged ELAV (UAS-eQ12H3) transgene.
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wanted to make sure that it is the amino acid sequence of
RRM3 that determines the interaction activity, not just
the presence of any RRM after the hinge. The latter could
be the case since the general structure of the RRM is quite
well conserved. To test the possibility, ELAV RRM1 or 2
were fused to the C-terminus of the hinge, and checked for
the interaction by the two-hybrid assay. Our results
showed that RRM1 or 2 do not substitute for RRM3,
indicating that amino acids unique to the RRM3 are
responsible for the interaction (Figure 3B column 10, data
not shown).
To ﬁnd the amino acids responsible for the interaction,
we looked for RRM3-speciﬁcally conserved residues.
Figure 3A shows an amino acid sequence alignment of
RRMs from three Drosophila, and four human ELAV-
family proteins. RRM3-speciﬁc conservations are indi-
cated by magenta, which are deﬁned as the amino acids
conserved among RRM3s, but not in RRM1 or 2.
Conserved amino acids among the RRM3s that are not
speciﬁc to RRM3 are indicated by blue. We chose the
underlined sequences (numbers 1–7) as the targets for the
mutational analysis. The sequence number 5 is not an
RRM3-speciﬁc conservation, and was chosen as a
negative control.
The eH3 construct was mutated by replacing one of the
underlined sequences in Figure 3A with the corresponding
sequence of ELAV RRM2. The interaction with eH3 was
tested by the two-hybrid assay. While mutation in
sequences 1, 2, 5 and 7 did not aﬀect the interaction
(Figure 3B columns 2, 3, 6 and 8), mutations in sequences
3, 4 and 6 caused loss of interaction (Figure 3B columns 4,
5 and 7), which indicated that the mutated amino acids
were essential for the interaction. The three essential
sequences 3, 4 and 6 are the ‘ETEE’ sequence adjacent
to the putative a-helix 1, the single tryptophan on the
a-helix 1, and ‘MTNY’ close to the putative a-helix 2,
respectively. Next, we asked if the three sequences are
suﬃcient to provide interaction activity to RRM2 when
introduced into the eH2 construct at the corresponding
sites. The hinge-RRM2 construct with the RRM3
sequences 3, 4 and 6 (eH3mu8) interacted with eH3
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Figure 2. Mapping of ELAV–ELAV interaction activity by the yeast two-hybrid assay. (A) Schematic representation of ELAV structure with the
N-terminus to the left. ELAV consists of three RNA recognition motifs (RRMs), the N-terminal AQ-rich region, and a hinge region between the
RRM2 and 3. (B and C) Yeast two-hybrid interactions among deletion mutants of ELAV. In the matrices, ‘+’ and ‘ ’ indicate positive and negative
interactions in the yeast two-hybrid assay, respectively. Schematics of the deletion mutants are shown upper and left sides of each matrix.
Boxes labeled with 1, 2 and 3 represent RRM1, 2 and 3, respectively. The bars next to the RRM1 and between RRM2 and 3 represent the AQ-rich
and hinge regions, respectively.
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play a critical role in ELAV–ELAV interaction. The
examination of expected positions of the identiﬁed amino
acids in relation to the tertiary structure of the RRM
revealed that most of them are exposed to the outside, and
thus qualiﬁed as candidates for the amino acids that
mediate the interaction (Figure 4).
The three sequences are notsufficient for RRM3
to function in vivo
Given that our results indicate RRM3 has a critical role in
ELAV–ELAV interaction, it is possible that RRM3 serves
mainly as a protein–protein interaction domain, not as an
RNA-binding domain. To test the possibility, we exam-
ined the in vivo function of ELAV with mutant RRM3 by
expressing them using the GAL4-UAS system. We made
four UAS-elav constructs: (i) the wild-type control
(eQ12H3); (ii) the W419E mutant (eQ12H3mu4) that is
presumably interaction defective; (iii) a mutant in which
RRM2 replaces RRM3 except for the sequences 3, 4 and 6
(eQ12H3mu8) and (iv) a mutant in which RRM2 replaces
RRM3 completely (eQ12H2) (see Figure 5C for sche-
matics). To evaluate the in vivo function of the mutant
proteins, we employed a GFP reporter gene (UnGA)
whose expression is dependent upon ELAV-regulated
ELAV ---ETRTNLIVNYLPQTMTEDEIRSLFSSVGEIESVKLIRDKSQVYIDPLN-----PQAPSKGQSLGYGFVNYVRPQDAEQAVNVLNGLRLQN--KTIKVSFARPS----
Rbp9 ---DPKTNLIVNYLPQTMSQDEIRSLFVSFGEVESCKLIRDKVTG------------------QSLGYGFVNYVKQEDAEKAINALNGLRLQN--KTIKVSIARPS----
Fne ---ESRTNLIVNYLPQTMTQEEMRSLFSSIGELESCKLVRDKVSGNLVLPASLTALNPALQQGQSLGYGFVNYVRAEDAEKAVNTLNGLRLQN--KVIKVSYARPS----
HuR ---IGRTNLIVNYLPQNMTQDELRSLFSSIGEVESAKLIRDKVAG------------------HSLGYGFVNYVTAKDAERAINTLNGLRLQS--KTIKVSYARPS----
HuB ---DSKTNLIVNYLPQNMTQEELKSLFGSIGEIESCKLVRDKITG------------------QSLGYGFVNYIDPKDAEKAINTLNGLRLQT--KTIKVSYARPS----
HuC ---DSKTNLIVNYLPQNMTQDEFKSLFGSIGDIESCKLVRDKITG------------------RDLGYGFVNYPDPNDADKAINTLNGLKLQT--KTIKVSYARPS----
HuD ---DSKTNLIVNYLPQNMTQEEFRSLFGSIGEIESCKLVRDKITG------------------QSLGYGFVNYIDPKDAEKAINTLNGLRLQT--KTIKVSYARPS----
ELAV SDAIKGANLYVSGLPKTMTQQELEAIFAPFGAIITSRILQNAGN-----------------DTQTKGVGFIRFDKREEATRAIIALNGTTPSSCTDPIVVKFSNTP----
Rbp9 SESIKGANLYVSGLPKNMTQSDLESLFSPYGKIITSRILCDNITDEHA-------------AGLSKGVGFIRFDQRFEADRAIKELNGTTPKNSTEPITVKFANNP----
Fne SESIKGANLYVSGLPKNLSQPDLEGMFASFGKIITSRILCDNIS------------------GLSKGVGFIRFDQRNEAERAIQELNGKTPKGYAEPITVKFANNP----
HuR SEVIKDANLYISGLPRTMTQKDVEDMFSRFGRIINSRVLVDQTT------------------GLSRGVAFIRFDKRSEAEEAITSFNGHKPPGSSEPIAVKFAANP----
HuB SASIRDANLYVSGLPKTMTQKELEQLFSQYGRIITSRILVDQVT------------------GISRGVGFIRFDKRIEAEEAIKGLNGQKPPGATEPITVKFANNP----
HuC SASIRDANLYVSGLPKTMSQKEMEQLFSQYGRIITSRILVDQVT------------------GVSRGVGFIRFDKRIEAEEAIKGLNGQKPLGAAEPITVKFANNP----
HuD SASIRDANLYVSGLPKTMTQKELEQLFSQYGRIITSRILVDQVT------------------GVSRGVGFIRFDKRIEAEEAIKGLNGQKPSGATEPITVKFANNP----
ELAV -----AYPIFIYNLAPETEEAALWQLFGPFGAVQSVKIVKDPTTN------------------QCKGYGFVSMTNYDEAAMAIRALNGYTMGN--RVLQVSFKTNKAK--
Rbp9 -----GWCIFVYNLAPDTEENVLWQLFGPFGAVQSVKVIRDLQSN------------------KCKGFGFVTMTNYEEAVLAIQSLNGYTLGN--RVLQVSFKTNKNKQT
Fne -----GWCIFVYNLAPETEENVLWQLFGPFGAVQSVKVIRDLQTS------------------KCKGFGFVTMTNYDEAVVAIQSLNGYTLGN--RVLQVSFKTNKTKTT
HuR -----GWCIFIYNLGQDADEGILWQMFGPFGAVTNVKVIRDFNTN------------------KCKGFGFVTMTNYEEAAMAIASLNGYRLGD--KILQVSFKTNKSHK-
HuB -----GWCIFVYNLAPDADESILWQMFGPFGAVTNVKVIRDFNTN------------------KCKGFGFVTMTNYDEAAMAIRSLNGYRLGD--RVLQVSFKTNKTHKA
HuC -----GWCIFVYNLSPEADESVLWQLFGPFGAVTNVKVIRDFTTN------------------KCKGFGFVTMTNYDEAAMAIASLNGYRLAE--RVLQVSFKTSKQHKA
HuD -----GWCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRDFNTN------------------KCKGFGFVTMTNYDEAAMAIASLNGYRLGD--RVLQVSFKTNKAHKS
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Figure 3. Uniquely conserved sequences in the RRM3 that are responsible for ELAV–ELAV interaction. (A) An amino-acid sequence alignment of
RRMs from three Drosophila, and four human ELAV-family proteins; ELAV, Rbp9, Fne, HuR, HuB, HuC and HuD. Amino acids that are
conserved among RRM3s but not at the same sites in RRM1 or 2 (RRM3-speciﬁc conservations) are indicated by magenta. Conserved amino acids
among the RRM3s that are not speciﬁc to RRM3 are shown by blue. Darker color indicates identical amino acids to those of ELAV RRM3, and
lighter color indicates conservative substitutions. Putative secondary structural elements are shown above. The seven underlined sequences were
chosen for the mutational analysis. (B) The eﬀect of mutations on the interaction. The hinge-RRM3 construct was mutated by replacing one of the
seven underlined sequences with the corresponding sequence of RRM2. The interactions between the mutants and the wild-type hinge-RRM3 were
tested by the two-hybrid assay. In the ﬁgure, the constructs above the ‘+’ or ‘ ’ box are activation-domain fusions, and the eH3 ‘bait’ construct on
the left is a DNA-binding-domain fusion. The loss of interaction activity of the mutants eH3mu3, 4 and 6 (columns 4, 5 and 7) suggests that the
mutated amino acids are essential for the interaction. Introduction of the three sequences, 3, 4 and 6, to RRM2 (eH3mu8 construct, column 9) was
suﬃcient to give the interaction activity to the hinge-RRM2. Photographs of representative testing and control plates are shown below.
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Although the reporter is transcribed ubiquitously, GFP is
expressed only when ELAV promotes the neural splicing
of the intron (Figure 5A). GFP expression from UnGA is
limited to neurons in the wild-type animals, but when
ELAV is ectopically expressed, GFP is also expressed
where ectopic ELAV is expressed (46; Figure 5B). We
ectopically expressed ELAV in the wing discs of the third
instar larvae using the dpp-GAL4 driver (43), and
measured the GFP expression level relative to the ectopic
ELAV level (see Materials and methods section for
details). The right panel of Figure 5C shows induced
GFP reporter expression levels by two independent
insertion lines of each UAS-elav construct, as fractions
of the mean value of the wild-type controls. The W419E
mutant showed a reduced level of GFP expression
compared to the wild-type construct, suggesting the
importance of multimerization for the alternative-splicing
regulation (Figure 5C). The mutant in which RRM3 was
replaced by RRM2 except for the sequences 3, 4 and 6
functioned no better than the RRM3/2 total replacement
mutant (Figure 5C). The result indicates that RRM3
requires more than the three sequences to function in vivo,
and implies that multimerization is not the only function
RRM3 performs.
DISCUSSION
Previous studies have suggested that the RRM3 of ELAV-
family proteins has a less important role in speciﬁc
RNA-binding than the other two RRMs. For example,
experiments using deletion constructs of Hu proteins
have shown that mutant proteins lacking RRM3 still bind
ARE eﬃciently (37,47,48). Yet, evolutionary conservation
of the RRM3 sequence is the strongest among the three
RRMs, which indicates an important function for RRM3.
In this study, we showed that ELAV RRM3 has a central
role in multimerization of the protein, and we believe that
the multifunctional aspect of RRM3 makes it the most
conserved RRM of the protein. It is noteworthy that
RRM3 of HuC and HuB has been shown to have a
dominant negative eﬀect on neural-phenotype-inducing
activity of the proteins (49). An explanation for this eﬀect
is competition between the full-length protein and the
RRM3 fragment for binding to the RNA substrates, as
shown by Gao and Keene (36). Considering our results,
however, one can conceive another possible mechanism
that the over-expression of the RRM3 fragment interferes
with multimerization of the full-length proteins.
Kasashima et al. (35) studied multimerization of Hu
proteins. They found that RRM3 of HuC showed the
strongest interaction activity in the yeast two-hybrid
system when full length HuB was used as bait, basically
agreeing with our result. However, when HuC RRM3 was
used as bait, a fragment containing both RRM1 and 2 also
showed strong interaction activity (35). In our yeast two-
hybrid experiment, similar constructs (e12 construct in
Figure 2B) did not show interaction with either the full
length ELAV or hinge-RRM3 fragment. This discrepancy
may come from the presence of an arbitrary threshold in
our system; i.e. we evaluate interaction by scoring colony
formation of the yeast, and weak interactions may fail to
be scored in principle. Therefore, it is possible that RRM1
and 2 also contribute to multimerization. In fact, we found
that the RRM1+2 fragment showed limited interaction
activity when the N-terminal AQ-rich region was added to
it (eQ12 construct in Figure 2B). Nonetheless, our results
suggest that the interaction activity of RRM3 is at least
stronger than that of RRM1 or 2. The three sequence
elements in the RRM3 we identiﬁed in this study are likely
to be important for multimerization of all ELAV-family
proteins, since they were identiﬁed as conserved sequences
among the family.
Structural studies have shown that the RRMs have a
well conserved general structure; i.e. four anti-parallel
b-strands form a b-sheet, and two a-helices are packed
against the b-sheet (6; Figure 4). Studies on RNA-bound
forms of RRMs have demonstrated that RRMs interacts
with RNA through the amino acids located on the b-sheet,
including those in the conserved short consensus
sequences ribonucleoprotein (RNP) 1 and 2 by which
RRM was initially deﬁned (4,5,7–9). It has been shown
that RRMs are also involved in protein–protein interac-
tions. In some cases, the RRM interacts with another
RRM (17,19,21), while in other cases, the RRM interacts
with non-RRM proteins (8,10–16,18,20). Amino acids on
the a-helices are involved in most interactions although
detailed mode of interaction varies from one case to
another. We identiﬁed three sequence elements that are
essential for ELAV–ELAV interaction, and also suﬃcient
to give the interaction activity to RRM2 when all of them
are introduced into it. All the three elements are estimated
to be located on or adjacent to the a-helices when we look
Thr (Glu)
Thr (Glu)
Met (Thr)
Gln (Glu) Glu (Trp)
Arg (Tyr)
Lys (Asn)
Asp (Thr)
Phe (Met)
Figure 4. Expected positions of the three sequences in relation to the
tertiary structure of the RRM. The RRM2 part of the crystal structure
of HuD associated with c-fos ARE (9; Protein Data Bank ID 1FXL) is
shown. The RRM1, linker region between RRM1 and 2, and c-fos
ARE RNA are omitted. The corresponding amino acid residues of the
three interaction sequences of ELAV RRM3 are shown in orange
(sequence 3), yellow (sequence 4) and purple (sequence 6). The labels
indicate the identity of the shown residues of HuD RRM2 and that of
the corresponding residues of ELAV RRM3 in the parentheses. All the
residues are exposed to the solvent except the phenylalanine in the
sequence 6. Columnar and ﬂat arrows represent a-helix and b-strand,
respectively. The a-helices 1 and 2 are labeled. The image is created by
the Cn3D software (National Center for Biotechnology Information).
1396 Nucleic Acids Research, 2008, Vol. 36, No. 4at the positions of the corresponding amino acids in
other RRMs for which the tertiary structures have been
determined (Figure 4). This suggests a model in which
the ELAV RRM3 interacts with another RRM3 through
the surface opposite to the RNA-binding surface of the
domain.
In our co-IP experiment, ELAV–ELAV interaction
required the presence of RNA. This observation raises the
question as to whether the interaction is based on protein–
protein interaction or is mediated by RNA. Although the
RNA-mediated interaction model could not be excluded
completely, the protein–protein interaction model is
preferred for the following reasons: (i) the three identiﬁed
important sequence elements for the interaction are all
located away from the putative RNA binding surface;
(ii) the mutations on the putative RNA binding surface
(mutants eH3mu2 and 5 in Figure 3B) that potentially
alter the binding speciﬁcity did not interfere with the
interaction. It has also been shown that HuD–HuD
interaction is greatly reduced with RNase treatment
although not completely abolished (35). We hypothesize
that a conformational change of the RRM upon RNA
binding ensures eﬃcient protein-protein interaction in
both ELAV and HuD cases. Interestingly, a recent study
on ARE-binding of HuR has revealed that RRM3 is
required for cooperative assembly of HuR oligomers on
RNA (37). The observation ﬁts the idea that the initial
binding of an ELAV-family protein on a target RNA
facilitates the protein-protein interaction between
RRM3s.
We ﬁnd that RRM2 with the three critical sequences
allows ELAV interaction in the yeast two-hybrid system,
but still fails to support the in vivo function. Thus,
additional sequences in RRM3 are also necessary for
ELAV function. This is consistent with the previous study
that suggests that the RNA binding ability of each RRM,
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Figure 5. In vivo functional analysis of the RRM3 mutants. (A) Schematic representation of the UnGA reporter gene. The UnGA has the alternatively
spliced intron from Nrg whose splicing is regulated by ELAV. It is transcribed ubiquitously, but GFP is expressed only when ELAV promotes the
neural splicing of the intron. (B) Ectopic expression of ELAV in the wing disc by the dpp-GAL4 driver leads to the GFP expression from UnGA.
Anti-ELAV (left panel) and anti-GFP (right panel) staining of a UnGA/+; dpp-GAL4/UAS-eQ12H3 wing disc are shown. The outline of the disc is
shown with a white line. (C) The wild-type control and three mutant forms of ELAV were expressed by the dpp-GAL4 driver. Two independent
insertion lines were used for each UAS construct. GFP expression levels in the wing disc were quantiﬁed, and normalized by ELAV expression levels.
The bars on the right panel show the averaged values of eight wing discs for each genotype, as fractions of the mean value of the wild-type controls.
The error bars show the 95% conﬁdence intervals. Bars labeled with diﬀerent letters (a–e) are signiﬁcantly diﬀerent at P<0.01 in the t-test.
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mutations that individually disrupt the RNA binding
ability of individual RRMs were unable to provide ELAV
function (40). Therefore, it is suggested that ELAV RRM3
is a bi-functional domain that interacts with both RNA
and protein.
One of the three critical sequence elements for ELAV–
ELAV interaction was the single tryptophan at the
position 419 (W419). Coincidentally, two independent
temperature-sensitive alleles of elav, elav
ts1 and elav
FliJ2,
have TAG and TGA stop codons at the site of W419,
respectively (50). In these two mutants, ELAV protein
with an apparent normal size is produced, along with a
truncated form. It is hypothesized that some form of
nonsense suppression occurs in these mutants, and
probably a diﬀerent amino acid substitutes the original
W419 (50). Further, it is suggested that the temperature
sensitivity of the mutants is due to impaired function of
the protein, rather than the thermolability of the protein,
because the amounts of either forms of ELAV are
unaﬀected by temperature (50). Since W419E substitution
strongly reduced multimerization activity in our yeast
two-hybrid experiment, we hypothesize that the amino
acid substitution resulted from the nonsense suppression
compromise multimerization of the protein, which leads to
the temperature sensitive phenotype of the mutants.
ELAV-family proteins have been shown to form multi-
meric complexes on their target RNA (34–37). It is likely
that multimerization is an integral part of the mechanism
by which ELAV-family proteins carry out their functions.
However, the structural basis of the multimer formation
remains unknown. In this study, we showed the impor-
tance of RRM3 for ELAV multimerization, and identiﬁed
three sequence elements that are essential for the interac-
tion. Our results suggest a rough model for a ELAV
multimer in which ELAV molecules interact with each
other by their RRM3s. Further structural and biochemical
studies are required to draw the complete picture of the
multimeric complex, and understand the physical mechan-
isms of RNA processing/stabilization by ELAV-family
proteins.
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